Gene and cytokines expression of multiple sclerosis and its therapeutic regimen: A systemic review

International Journal of Drug Development and Research

Volumn 4, Issue 3, 2012, Pages 55-66

  Srivastava, Parul ^a   Mujtaba, Md Ali ^b   Singhal, Manmohan ^a  

^a JAIPUR NATIONAL UNIVERSITY   (India)

^b HAMDARD UNIVERSITY   (India)

Author keywords

Cytokines; Experimental autoimmune encephalomyelitis; Gene expression; Multiple sclerosis

Indexed keywords

CYTOKINE;

ALLERGIC ENCEPHALOMYELITIS; DEMYELINATION; DISEASE CLASSIFICATION; GENE EXPRESSION; HUMAN; INFLAMMATION; MULTIPLE SCLEROSIS; NERVE CELL DEGENERATION; NONHUMAN; PRIMARY PROGRESSIVE MULTIPLE SCLEROSIS; PROGRESSIVE RELAPSING MULTIPLE SCLEROSIS; PROTEIN EXPRESSION; REVIEW; SYSTEMATIC REVIEW;

EID: 84874291570     PISSN: None     EISSN: 09759344     Source Type: Journal    
DOI: None     Document Type: Review

References (21)

1. Wang C, Li Y, Proctor TM, Vandenbark AA, Offner H. Down-Modulation of Programmed Death 1 Alters Regulatory T Cells and Promotes Experimental Autoimmune Encephalomyelitis. J Neurosci Res. 2010; 88(1): 7-15.
2. Vosoughi R, Freedman MS. Review of Therapy of MS. Clinical Neurology and Neurosurgery. 2010; 112: 365-385.
3. Friese MA, Montalban X, Willcox N, Bell JI, Marti R, Fugger L. The value of animal models for drug development in multiple sclerosis. Brain. 2006; 129: 1940-1952
4. Pedotti R, Voss JJD, Steinman L, Galli SJ. Involvement of both 'allergic' and'autoimmune' mechanisms in EAE, MS and other autoimmune diseases. TRENDS in Immunology. 2003; 24(9): 479-484.
5. Perez-Nievas BG, Garcia-Bueno, Madrigal JLM, Leza JC. Chronic immobilisation stress ameliorates clinical score and neuroinflammation in a MOG-induced EAE in Dark Agouti rats: mechanisms implicated. Journal of Neuroinflammation. 2010; 7(60): 1-13.
6. Weber MS, Benkhoucha M, Lehmann-Horn K, Hertzenberg D, Sellner J, Santiago-Raber ML, Chofflon M, Hemmer B, Zamvil SS, Lalive PH. Repetitive Pertussis Toxin Promotes Development of Regulatory T Cells and Prevents Central Nervous System Autoimmune Disease. PLoS ONE. 2010; 5(12): e16009.
7. Ringold S, Richard MG. Multiple Sclerosis. The Journal of the American Medical Association. 2006; 296(23): 2880.
8. Peiris M, Monteith GR, Thomson SJR, Cabot PJ. A model of experimental autoimmune encephalomyelitis (EAE) in C57BL/6 mice for the characterisation of intervention therapies. Journal of Neuroscience Methods. 2007; 163: 245-254.
9. + T cells for sustained CNS inflammation during chronic EAE. Journal of Neuroimmunology. 2009; 213: 60-68.
10. Castro GM, Zanin ME, Oliveira DV, Vilella CA, Ashimine R, Zollner RL. Th1 and Th2 cytokine immunomodulation by gangliosides in experimental autoimmune encephalomyelitis. Cytokine. 2004; 26: 155-163.
11. Wiist S, Brandt J, Tischner D, Kleiman A, Tuckermann JP, Gold R, Liihder F, Reichardt HM. Peripheral T cells are the therapeutic targets of glucocorticoids in experimental autoimmune encephalomyelitis. The Journal of Immunology. 2008; 180: 8434-8443.
12. Jones MV, Nguyen TT, Deboy CA, Griffin JW, Whartenby KA, Kerr DA, Calabresi PA. Behavioral and pathogical outcomes in MOG 35-55 experimental autoimmune encephalomyelitis. Journal of Neuroimmunology. 2008; 199: 83-93.
13. Mix E, Meyer-Rienecker H, Hartung H, Zettle UK. Animal models of multiple sclerosis-Potentials and limitations. Progress in Neurobiology. 2010; 92: 386-404.
14. Donia M, Mangano K, Quattrocchi C, Fagone P, Signorelli S, Magro G, Sfacterias A, Bendtzen K, Nicoletti F. Specific and strain-independent effects of dexamethasone in the prevention and treatment of experimental autoimmune encephalomylelitis in rodents. Scandinavian Journal of Immunology. 2010; 72: 396-407.
15. Gold R, Linington C, Lassmann H. Understanding pathogenesis and therapy of multiple sclerosis via animal models: 70 years of merits and culprits in experimental autoimmune encephalomyelitis research. Brain. 2006: 129: 1953-1971
16. Ibrahim SM, Mix E, Bottcher T, Koczan D, Gold R, Rolfs A, Thiesen HJ. Gene expression profiling of the nervous system in the murine experimental autoimmune encephalomylelitis. Brain.2001; 124: 1927-1938.
17. Nicot A, Ratnakar PV, Ron Y, Chen CC, Elkabes S. Regulation of gene expression in experimental autoimmune encephalomyelitis indicates early neuronal dysfunction. Brain. 2003; 126: 398-412.
18. Deluca HF, Cantorna MT. Vitamin D: its role and uses in immunology. FASEB J. 2001; 15: 2579-2585.
19. Cantorna MT. Vitamin D and autoimmunity: Is vitamin D status an environmental factor affecting autoimmune disease prevalence. PSEBM. 2000; 223: 230-233.
20. Imitola J, Chitnis T, Khoyry SJ. Cytokines in multiple sclerosis: from bench to beside. Pharmacology and Therapeutics. 2005; 106: 163-177.
21. Hadaway LC. Immunosupressive treatment of multiple sclerosis. NITA. 1985; 8: 503-505.